Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|July 3, 2025
The contribution of BTK signaling in myeloid cells to neuroinflammationClaudia Bassani, Marta Molinari, Valentina Romeo, et al.Frontiers in Immunology|April 24, 2020
Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced NeurodegenerationEmanuela Colombo, Claudia Bassani, Anthea De Angelis, et al.Molecules (Basel, Switzerland)|November 21, 2020
Laquinimod Modulates Human Astrocyte Function and Dampens Astrocyte-Induced Neurotoxicity during InflammationEmanuela Colombo, Rosaria Pascente, Daniela Triolo, et al.Frontiers in Immunology|September 3, 2019
Loss of Circulating CD8+ CD161<sup>high</sup> T Cells in Primary Progressive Multiple SclerosisMassimo Acquaviva, Claudia Bassani, Nicole Sarno, et al.Frontiers in Immunology|August 7, 2024
Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosisDavide De Federicis, Claudia Bassani, Rosaria Rita Chiarelli, et al.Journal of Autoimmunity|May 26, 2023
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunityEmanuela Colombo, Marco Di Dario, Ramesh Menon, et al.Cancer Research|April 11, 2015
SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute LeukemiasCaterina Vitali, Claudia Bassani, Claudia Chiodoni, et al.Proceedings of the National Academy of Sciences of the United States of America|June 29, 2021
Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytesEmanuela Colombo, Daniela Triolo, Claudia Bassani, et al.Neurobiology of Disease|September 20, 2024
Astrocyte TrkB promotes brain injury and edema formation in ischemic strokeEmanuela Colombo, Marco Bacigaluppi, Michela Bartoccetti, et al.Brain, Behavior, and Immunity|August 3, 2024
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomicsMaryam Omrani, Rosaria Rita Chiarelli, Massimo Acquaviva, et al.Pageof 2